Hospital Pharmacists' Report

HOSPITAL REPORT

Pharmacist-directed care for HIV patients provides earlier viral suppression

HIV patients whose antiretroviral therapy was initiated and managed by pharmacists achieved earlier viral suppression compared with those managed by a primary HIV clinician. More

FDA

First biosimilar in U.S. now available

Sandoz announced that Zarxio (filgrastim-sndz) is now available. More

EDITOR'S CHOICE

DPP-4 inhibitors may cause severe joint pain

FDA said that sitagliptin, saxagliptin, linagliptin, and alogliptin may cause joint pain, and their labels have been revised to include this risk. More

Inside The Latest Issue

Safeguarding the U.S. supply chain

"Pharmacists are the drug experts. Call us first!"

Nine tips on how to manage like a boss

September 08, 2015

Continuing education

Primer on Inhalers and nebulizers: August 2015 CPE

MTM essentials for COPD management: Part 2

MTM essentials for COPD management: Part 1

Get the free app!

About Drug Topics' Hospital Pharmacist Report

Because you are currently subscribed to Drug Topics magazine, and because of your involvement at pharmacies located within healthcare facilities, we thought you might be interested in receiving our weeklyHospital Pharmacist Report e-newsletter. This e-newsletter is specifically designed for hospital pharmacists, and will provide you with updates between print issues, as well as on-the-spot meeting coverage at key meetings, delivered right to your inbox!

No further action is required from you if you would like to continue receiving Drug Topics' Hospital Pharmacist Report e-newsletter; however, if you prefer not to receive these messages, simply click the unsubscribe link below and you will be immediately removed from our mailing list.

Editorial Questions? Contact the Editorial Team Click Here. Sales, Reprints, Classified questions? Contact the Sales Team Click Here.

UBM MEDICA